IL-18 contributes to NK cell activation by upregulating the expression of perforin and granzymes, and when used in conjunction with IL-12 or IL-15, it can significantly boost NK cell-mediated cytotoxicity against various cancer cell lines (250). This evidence concerns the gene IL15 and cancer.